Worldwide, approximately 3 million die each year from tobacco-related disease. Many smokers are unable or unwilling to quit. As a consequence, consideration has been given to reduction of tobacco toxin exposure as a complement to prevention and treatment to reduce the health burdens associated with tobacco use. Basic questions related to assessing the feasibility of potential reduced exposure products and methods remain unanswered.
The specific aims of this TTURC continue to be to comprehensively examine various aspects of tobacco harm reduction: 1) effective methods to reduce tobacco toxin exposure and disease risk; 2) biomarkers to assess this reduction; 3) mechanisms associated with reductions in tobacco toxin exposure; 4) individual differences that moderate exposure and disease risk; and 5) the role of this approach in the treatment of smokers. Project 1, Lung carcinogen biomarkers in long-term tobacco users, will examine the predictive validity ofbiomarkers, some of which are used in Project 3, for lung cancer. Project 2, Nicotine exposure in rats, will focus on developing animal models and interventions for nicotine exposure reduction and compensation. Project 3, Methods for exposure reduction in humans, paralleling methods described in Project 2, will examine mechanisms, moderators and outcomes of various exposure reduction strategies. Project 4, Longitudinal care: smoking reduction to aid cessation, will determine if a longitudinal care intervention that includes a reduced tobacco exposure treatment approach, compared to a discrete care model, will improve tobacco abstinence. Three cores- the Administration, Communications, and Theory Core, the Biomarkers Core and the Design and Analysis Core will provide critical support for these projects. Mechanisms to ensure a transdisciplinary approach to science include: 1) a multidiscipliuary team of investigators with expertise ranging from organic chemistry to behavioral sciences to epidemiology, 2) a shared conceptual model or framework which integrates models for harm reduction with tobacco treatment; 3) shared methodologies; 4) mechanisms for communication and translation; 5) pilot projects to expand the scope of the center and engage additional scientists; and 6) a training program to mentor preand post-doctoral students, and junior faculty. The results of research from this TTURC will provide the scientific basis for urgent policy, public education, and regulatory efforts to reduce tobacco harm.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA013333-09
Application #
7240426
Study Section
Special Emphasis Panel (ZCA1-GRB-I (O1))
Program Officer
Montoya, Ivan
Project Start
1999-09-30
Project End
2009-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$1,799,605
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Psychiatry
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2016) Longitudinal Care Improves Cessation in Smokers Who Do Not Initially Respond to Treatment by Increasing Cessation Self-Efficacy, Satisfaction, and Readiness to Quit: A Mediated Moderation Analysis. Ann Behav Med 50:58-69
Konorev, Dmitri; Koopmeiners, Joseph S; Tang, Yijin et al. (2015) Measurement of the Heterocyclic Amines 2-Amino-9H-pyrido[2,3-b]indole and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Urine: Effects of Cigarette Smoking. Chem Res Toxicol 28:2390-9
Hatsukami, Dorothy K; Donny, Eric C; Koopmeiners, Joseph S et al. (2015) Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev 24:472-6
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2014) The relation between social support and smoking cessation: revisiting an established measure to improve prediction. Ann Behav Med 47:369-75
Oliver, Andrew J; Jensen, Joni A; Vogel, Rachel I et al. (2013) Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects. Nicotine Tob Res 15:88-92
Knezevich, Aleksandar; Muzic, John; Hatsukami, Dorothy K et al. (2013) Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans. Nicotine Tob Res 15:591-5
Anderson, Kristin E; Mongin, Steven J; Sinha, Rashmi et al. (2012) Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog 51:128-37
Stepanov, Irina; Knezevich, Aleksandar; Zhang, Liqin et al. (2012) Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control 21:44-8
Hecht, Stephen S; Stepanov, Irina; Hatsukami, Dorothy K (2011) Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tob Control 20:443
Harris, Andrew C; Pentel, Paul R; Burroughs, Danielle et al. (2011) A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats. Psychopharmacology (Berl) 217:153-66

Showing the most recent 10 out of 132 publications